T1 mapping using a saturation recovery sequences at 3 Tesla MRI in hypertrophic cardiomyopathy.

T1 mapping using a saturation recovery sequences at 3 Tesla MRI in hypertrophic cardiomyopathy. - T1 mapping in hypertrophic cardiomyopathy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017848

Enrollment

Registered

2015-07-01

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertrophic cardiomyopathy

Interventions

Magnescope 0.2ml/kg, once

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with HCM who underwent cardiac MRI. 2) Volunteer who be obtained informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria were any contraindications to gadolinium contrast agent.

Design outcomes

Primary

Measure	Time frame
Primary outcome is investigation of the T1 values of the HCM and controls.	—

Countries

Japan

Contacts

Public ContactRyo ogawa

Ehime University Graduate School of Medicine Department of Radiology

rpush137ed@gmail.com089-960-5371

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026